Received government funding or funding expected in current financial year
No
Business Relationships
TheraPsil is not a subsidiary of any other parent companies.
TheraPsil is not a coalition.
Beneficiaries of the Lobbying Activity
The activities of TheraPsil are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
TheraPsil does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
What is being lobbied?
Subject Matters
Constitutional Issues
Health
Subject Matter Details
Legislative Proposal, Bill or Resolution, Regulation
Title: Development of Psilocybin Access for Medical Purposes Regulations, and related regulations under the Controlled Drugs and Substances Act and the Food and Drugs Act.
Description: The lobbying activity is directed to establishment of regulations under the CDSA and FDA that allow access to regulated psilocybin products for medical purposes, consistent with Canada’s obligations under United Nations drug control conventions. This regulation would support medical access for patients and access for training purposes for physicians.
This activity proposes changes to Parts G and J of the Food and Drug Regulations, and creation of new regulations that are under the CDSA and the FDA. No changes to any Act of Parliament are proposed - only regulations under the FDA and CDSA.
Who is being lobbied?
Government Institutions
Health Canada (HC)
Communication techniques
Communication techniques that have been used or are expected to be used in the course of the undertaking: